找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Depression and Anxiety in Patients with Chronic Respiratory Diseases; Amir Sharafkhaneh,Abebaw Mengistu Yohannes,Mark E. Book 2017 Springe

[复制链接]
楼主: 复杂
发表于 2025-3-28 17:06:45 | 显示全部楼层
发表于 2025-3-28 20:00:33 | 显示全部楼层
Depression and Anxiety in the Cystic Fibrosis Population,ound to be the driving force of the psychopathology. Proposed causes of depression and anxiety in CF patients include pulmonary symptoms, especially dyspnea and air hunger, as well as vitamin D deficiency, abnormal body image, social stigma, time-consuming treatment regimens, and facing their own mo
发表于 2025-3-29 02:39:33 | 显示全部楼层
发表于 2025-3-29 03:43:18 | 显示全部楼层
Sleep-Disordered Breathing and Mental Illness,–70 million Americans suffer from a chronic disorder of sleep and wakefulness, hindering daily functioning and adversely affecting health. Insomnia is the most common sleep disorder, followed by sleep apnea and restless legs syndrome (RLS). Obstructive sleep apnea (OSA) is by far the most common for
发表于 2025-3-29 10:19:15 | 显示全部楼层
The Impact of Comorbidities in Patients with Chronic Respiratory Diseases,is, sleep apnoea syndrome, pneumoconiosis and pleural diseases are common respiratory diseases worldwide. They present similar symptoms such as breathlessness on exertion, excess mucous production, chronic cough and wheezing. When these conditions are not adequately treated and/or become chronic may
发表于 2025-3-29 12:01:38 | 显示全部楼层
Non-pharmacological Interventions to Manage Depression and Anxiety Associated with Chronic Respiratbut may also involve significant changes or challenges in daily activities, social relationships, self-perception and emotional functioning. The physical symptoms that are persistent in nature and the degenerative trajectories of disease contribute to psychological responses that impact the patients
发表于 2025-3-29 19:06:31 | 显示全部楼层
Pharmacological Therapy and Anxiolytics in Patients with Respiratory Diseases,th their daily activities. This section focuses primarily on antidepressant drug trials that have been conducted in patients with COPD and major depression. It will also examine the benefits of anxiolytics for this patient group. Both selective serotonin reuptake inhibitor (SSRI) and tricyclic antid
发表于 2025-3-29 23:35:05 | 显示全部楼层
发表于 2025-3-30 00:11:50 | 显示全部楼层
Book 2017 management options are outlined. Indeed recent studies indicate a far higher prevalence of depression and anxiety in patients afflicted with chronic respiratory conditions than in patients with other chronic disorders. Unlike other publications in the field of pulmonary disease, .Depression and Anx
发表于 2025-3-30 04:47:14 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 08:29
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表